Literature DB >> 15259513

Comparative studies of superoxide production by microbial wall product-primed neutrophils in ulcerative colitis.

Sara Elsøe Nielsen1, Ben Vainer, Ole Haagen Nielsen.   

Abstract

A diminished tolerance to the normal gut bacterial flora has been suggested to be pathogenic in ulcerative colitis (UC) and the aim of this study was to evaluate the priming effect of selected bacterial wall products on UC neutrophil granulocytes. Neutrophils from 10 UC patients and 10 healthy controls were primed with bacterial lipoprotein (BLP) or lipopolysaccharide (LPS) and subsequently activated. Extracellular superoxide production was measured by the cytochrome c reduction assay. Priming neutrophils with BLP or LPS dose dependently increased the superoxide production in both UC and controls (P < 0.01), and BLP was more potent than LPS (P < 0.05). No differences were found between UC and controls. UC neutrophils do not seem to have an intrinsic abnormality with reduced tolerance to bacterial substances. However, bacterial wall products such as BLP modify neutrophil tissue-destruction mechanisms and might be pivotal for perpetuation of chronic colonic inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259513     DOI: 10.1023/b:ddas.0000030103.85580.d6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock.

Authors:  Jiang Huai Wang; Majella Doyle; Brian J Manning; Siobhan Blankson; Qiong Di Wu; Colm Power; Ronan Cahill; H Paul Redmond
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

3.  Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis.

Authors:  Y Shiratora; S Aoki; H Takada; H Kiriyama; K Ohto; K Hai; H Teraoka; S Matano; K Matsumoto; K Kamii
Journal:  Digestion       Date:  1989       Impact factor: 3.216

4.  Activation and signaling status of human lamina propria T lymphocytes.

Authors:  L Qiao; G Schürmann; M Betzler; S C Meuer
Journal:  Gastroenterology       Date:  1991-12       Impact factor: 22.682

5.  Serum antibodies to Bacteroides species in chronic inflammatory bowel disease.

Authors:  M Tvede; S Bondesen; O H Nielsen; S N Rasmussen
Journal:  Scand J Gastroenterol       Date:  1983-09       Impact factor: 2.423

6.  Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14.

Authors:  A M Soler-Rodriguez; H Zhang; H S Lichenstein; N Qureshi; D W Niesel; S E Crowe; J W Peterson; G R Klimpel
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 7.  Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous?

Authors:  L Kruidenier; H W Verspaget
Journal:  Aliment Pharmacol Ther       Date:  2002-12       Impact factor: 8.171

8.  Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.

Authors:  Y Miyachi; A Yoshioka; S Imamura; Y Niwa
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

9.  Effect of 5-aminosalicylic acid and analogous substances on superoxide generation and intracellular free calcium in human neutrophilic granulocytes.

Authors:  O H Nielsen; P N Bouchelouche; D Berild; I Ahnfelt-Rønne
Journal:  Scand J Gastroenterol       Date:  1993-06       Impact factor: 2.423

10.  Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid.

Authors:  I Ahnfelt-Rønne; O H Nielsen; A Christensen; E Langholz; V Binder; P Riis
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

View more
  1 in total

Review 1.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.